アンジオテンシン変換酵素（ACE）阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Angiotensin Converting Enzyme (ACE) Inhibitors Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-00578 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・治療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、アンジオテンシン変換酵素（ACE）阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。アンジオテンシン変換酵素（ACE）阻害剤の種類別市場規模（スルフヒドリル含有剤、ジカルボン酸塩含有剤、ホスホン酸塩含有剤）、用途別市場規模（高血圧、心血管疾患、腎臓病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Sanofi、Merck、Pfizer、Eli Lilly、Novartis、Bayer、Jhonson and Johnson、Astra Zeneca、Bristol-Myers Squibb、GSK、Teva Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・アンジオテンシン変換酵素（ACE）阻害剤の北米市場（アメリカ、カナダ、メキシコ） ・アンジオテンシン変換酵素（ACE）阻害剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アンジオテンシン変換酵素（ACE）阻害剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アンジオテンシン変換酵素（ACE）阻害剤の南米市場（ブラジル、アルゼンチン） ・アンジオテンシン変換酵素（ACE）阻害剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：スルフヒドリル含有剤、ジカルボン酸塩含有剤、ホスホン酸塩含有剤 ・用途別分析：高血圧、心血管疾患、腎臓病、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Angiotensin Converting Enzyme (ACE) Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Angiotensin Converting Enzyme (ACE) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Angiotensin Converting Enzyme (ACE) Inhibitors market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Angiotensin Converting Enzyme (ACE) Inhibitors market has been segmented into
Sulfhydryl-containing Agents
Dicarboxylate-containing Agents
Phosphonate-containing Agents

By Application, Angiotensin Converting Enzyme (ACE) Inhibitors has been segmented into:
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Angiotensin Converting Enzyme (ACE) Inhibitors market presented in the report. This section sheds light on the sales growth of different regional and country-level Angiotensin Converting Enzyme (ACE) Inhibitors markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Angiotensin Converting Enzyme (ACE) Inhibitors market.

The report offers in-depth assessment of the growth and other aspects of the Angiotensin Converting Enzyme (ACE) Inhibitors market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Analysis
Angiotensin Converting Enzyme (ACE) Inhibitors competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Angiotensin Converting Enzyme (ACE) Inhibitors sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Angiotensin Converting Enzyme (ACE) Inhibitors sales, revenue and market share for each player covered in this report.

The major players covered in Angiotensin Converting Enzyme (ACE) Inhibitors are:
Abbott Laboratories
Sanofi
Merck
Pfizer
Eli Lilly
Novartis
Bayer
Jhonson and Johnson
Astra Zeneca
Bristol-Myers Squibb
GSK
Teva Pharmaceutical

Among other players domestic and global, Angiotensin Converting Enzyme (ACE) Inhibitors market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Angiotensin Converting Enzyme (ACE) Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors, with price, sales, revenue and global market share of Angiotensin Converting Enzyme (ACE) Inhibitors in 2018 and 2019.
Chapter 3, the Angiotensin Converting Enzyme (ACE) Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiotensin Converting Enzyme (ACE) Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Angiotensin Converting Enzyme (ACE) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Angiotensin Converting Enzyme (ACE) Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Sulfhydryl-containing Agents
1.2.3 Dicarboxylate-containing Agents
1.2.4 Phosphonate-containing Agents
1.3 Market Analysis by Application
1.3.1 Overview: Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Overview of Global Angiotensin Converting Enzyme (ACE) Inhibitors Market
1.4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer SWOT Analysis
2.7.4 Bayer Product and Services
2.7.5 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Jhonson and Johnson
2.8.1 Jhonson and Johnson Details
2.8.2 Jhonson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Jhonson and Johnson SWOT Analysis
2.8.4 Jhonson and Johnson Product and Services
2.8.5 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Astra Zeneca
2.9.1 Astra Zeneca Details
2.9.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Astra Zeneca SWOT Analysis
2.9.4 Astra Zeneca Product and Services
2.9.5 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb SWOT Analysis
2.10.4 Bristol-Myers Squibb Product and Services
2.10.5 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 GSK
2.11.1 GSK Details
2.11.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 GSK SWOT Analysis
2.11.4 GSK Product and Services
2.11.5 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teva Pharmaceutical
2.12.1 Teva Pharmaceutical Details
2.12.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Teva Pharmaceutical SWOT Analysis
2.12.4 Teva Pharmaceutical Product and Services
2.12.5 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer Market Share in 2019
3.3.2 Top 6 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Market Share by Regions (2015-2020)
4.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Market Share by Regions (2015-2020)
4.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
4.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
4.5 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Market Share by Country (2015-2020)
5.1.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Market Share by Country (2015-2020)
5.2 United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
5.3 Canada Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
5.4 Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Market Share by Country (2015-2020)
6.1.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Market Share by Country (2015-2020)
6.2 Germany Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
6.3 UK Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
6.4 France Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
6.5 Russia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
6.6 Italy Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Market Share by Regions (2015-2020)
7.2 China Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
7.3 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
7.4 Korea Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
7.5 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
7.7 Australia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Market Share by Country (2015-2020)
8.1.2 South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Market Share by Country (2015-2020)
8.2 Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
8.3 Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
9.3 Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
9.4 Egypt Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
9.5 South Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Market Share by Type (2015-2020)
10.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Market Share by Type (2015-2020)
10.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2015-2020)
11 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment by Application
11.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2015-2020)
11.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Application (2015-2020)
11.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2015-2020)
12 Market Forecast
12.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Growth Rate (2021-2025)
12.2 Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast by Regions (2021-2025)
12.2.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025)
12.2.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025)
12.2.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025)
12.2.4 South America Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025)
12.2.5 Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025)
12.3 Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast by Type (2021-2025)
12.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Type (2021-2025)
12.3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Type (2021-2025)
12.4 Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast by Application (2021-2025)
12.4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Application (2021-2025)
12.4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Angiotensin Converting Enzyme (ACE) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 9. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 10. Abbott Laboratories SWOT Analysis
Table 11. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 12. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 15. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 16. Sanofi SWOT Analysis
Table 17. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 18. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 21. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 22. Merck SWOT Analysis
Table 23. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 24. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 27. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 30. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 33. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 34. Eli Lilly SWOT Analysis
Table 35. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 36. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 39. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 42. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Bayer Basic Information, Manufacturing Base and Competitors
Table 44. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 45. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 46. Bayer SWOT Analysis
Table 47. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 48. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table 50. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 51. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 52. Jhonson and Johnson SWOT Analysis
Table 53. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 54. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 56. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 57. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 58. Astra Zeneca SWOT Analysis
Table 59. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 60. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 62. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 63. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 64. Bristol-Myers Squibb SWOT Analysis
Table 65. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 66. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 69. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 70. GSK SWOT Analysis
Table 71. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 72. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Major Business
Table 75. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 76. Teva Pharmaceutical SWOT Analysis
Table 77. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product and Services
Table 78. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Manufacturer (2018-2019) (K MT)
Table 80. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Regions (2015-2020) (K MT)
Table 82. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Regions (2015-2020)
Table 83. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 85. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2015-2020)
Table 86. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 88. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 89. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2015-2020)
Table 90. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Regions (2015-2020) (K MT)
Table 92. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 95. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2015-2020)
Table 96. South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 99. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 102. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2015-2020) (K MT)
Table 103. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Type (2015-2020)
Table 104. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2015-2020) (USD Million)
Table 105. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Type (2015-2020)
Table 106. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2015-2020) (K MT)
Table 107. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Application (2015-2020)
Table 108. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Regions (2021-2025) (K MT)
Table 109. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Regions (2021-2025)
Table 110. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Type (2021-2025) (K MT)
Table 111. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Type (2021-2025)
Table 112. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Application (2021-2025)
Table 113. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Angiotensin Converting Enzyme (ACE) Inhibitors Picture
Figure 2. Global Sales Market Share of Angiotensin Converting Enzyme (ACE) Inhibitors by Type in 2019
Figure 3. Sulfhydryl-containing Agents Picture
Figure 4. Dicarboxylate-containing Agents Picture
Figure 5. Phosphonate-containing Agents Picture
Figure 6. Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application in 2018
Figure 7. Hypertension Picture
Figure 8. Cardiovascular Diseases Picture
Figure 9. Kidney Diseases Picture
Figure 10. Other Picture
Figure 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Manufacturer in 2019
Figure 32. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Regions (2015-2020)
Figure 39. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Regions in 2018
Figure 40. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
Figure 41. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
Figure 43. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020)
Figure 45. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2015-2020)
Figure 47. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries in 2018
Figure 48. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2018
Figure 50. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2019
Figure 56. Germany Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Regions 2019
Figure 64. China Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries in 2019
Figure 71. South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2019
Figure 72. Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel

---